ALB and esophageal squamous cell carcinoma: This study found that CONUT and SIS score had a clinical value in predicting the effect and possible toxic and side effects of patient with R/M ESCC receiving second-line immunotherapy, which had better power for predicting prognosis than other hematology indexes like albumin, total cholesterol and prognostic nutritional index (PNI).